• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX

PRESCIENT THERAPEUTICS LIMITED - Research Articles

4.65% ! 4.1¢
Market Cap $40.05M  !

Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing... Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Get the latest company research directly integrated within your HotCopper experience. To get started simply connect your account with your preferred Research Partner.

Our research partner is Wise-owl


PRESCIENT THERAPEUTICS LIMITED

  • There are currently no articles available for PTX (ASX).

Other Market Research Available

Disclaimer and limitation of liability: This is a paid advertisement. HotCopper does not endorse, approve or have responsibility for any offer or statements made and is not a publisher or have editorial influence for any research provider.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $40.05M
Open High Low Value Volume
4.3¢ 4.3¢ 4.1¢ $73.49K 1.764M

Buyers (Bids)

No. Vol. Price($)
25 1701798 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 236496 1
View Market Depth
Last trade - 15.59pm 08/08/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.